Systemic lupus erythematosus(SLE)is a systemic autoimmune disease,patients generally have a large number of autoantibodies in the blood,and show multi-organ involvement,the disease process is slow and easy to recur,seriously threatening the health of patient.At present,the cause of this disease is unknown,and there is no known cure,and the goal of treatment is to slow the progression of the disease and relieve symptoms.In this paper,SLE therapeutics currently on the market and under study are searched through the Lilac Garden Insight database,and briefly analyzed them from three dimensions:drug research institute stage,drug research target selection and drug component classification,in order to form a reference for follow-up drug research and clinical treatment selection.